Jean-PierreLindenmayerMD

Psychiatry • New York, NY

Clinical Professor of Psychiatry, NYU School of Medicine

Join to view full profile

Dr. Lindenmayer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lindenmayer's full profile

Already have an account?

Office
18 East 77th Street
New York, NY 10021
Phone+1 212-249-2720

Fax+1 212-249-4116
Is this information wrong?

Education & Training

SUNY Downstate Health Sciences UniversityResidency, Psychiatry, 1970 - 1974
Brooklyn Hospital CenterInternship, Internal Medicine, 1969 - 1970
University of Basel Faculty of MedicineClass of 1967

Certifications & Licensure

NY State Medical License 1974 - 2024
American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

Top Doctors: New York Metro Area Castle Connolly, 2002-2014
Super Doctor SuperDoctors.com

Clinical Trials

Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia Start of enrollment: 2004 Oct 01
Completed
Phase 4
High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder Start of enrollment: 2004 Dec 01
Completed
Phase 2, Phase 3
Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder Start of enrollment: 2003 Sep 01
Completed
Phase 2, Phase 3
Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills Training Start of enrollment: 2006 Sep 01
Completed
Not Applicable
Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder Start of enrollment: 2006 Nov 01
Completed
Phase 4
Outcome Evaluation of Solutions for Wellness and Team Solutions Program in Patients With Severe Mental Illness Start of enrollment: 2006 Sep 01
Completed
Not Applicable
Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia Start of enrollment: 2007 Apr 01
Unknown status
Not Applicable
Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder Start of enrollment: 2008 Feb 01
Withdrawn
Phase 2
Cognitive Skills Training Using Computer for Patients With Severe Mental Illness Start of enrollment: 2003 Feb 01
Completed
Phase 4
Transcranial Direct-current Stimulation (tDCS) in Treatment Refractory Auditory Hallucinations Start of enrollment: 2014 Apr 01
Completed
Not Applicable
Can Cognitive Training Decrease Reactive Aggression? Start of enrollment: 2016 Aug 16
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

1 citations
Computerized cognitive and social cognition training in schizophrenia for impulsive aggression.
Anzalee Khan, Jean-Pierre Lindenmayer, Beverly Insel, Mary Seddo, Ecem Demirli, Kayla DeFazio, Mark Sullivan, Matthew J Hoptman, Anthony O Ahmed> ;Schizophrenia Research. 2023 Jun 1
SIBAT-A Computerized Assessment Tool for Suicide Ideation and Behavior: Development and Psychometric Properties.
Larry Alphs, Dong-Jing Fu, David Williamson, Carol Jamieson, John Greist, Magdalena Harrington, Jean-Pierre Lindenmayer, Cheryl McCullumsmith, David V Sheehan, Richard...> ;Innovations in Clinical Neuroscience. 2022 Aug 12
1 citations
Effects of Clozapine on Neurocognitive Functions in Schizophrenia: A Naturalistic Comparison to Non-clozapine Antipsychotics.
J P Lindenmayer, Beverly J Insel, Anzalee Khan, McKenzie Osborne, Abraham Goldring, Mary Seddo> ;Innovations in Clinical Neuroscience. 2022 Jan 31
3 citations
Healthcare Provider Engagement with a Novel Dashboard for Tracking Medication Ingestion: Impact on Treatment Decisions and Clinical Assessments for Adults with Schizop...
Jeffrey M Cochran, Hui Fang, John G Sonnenberg, Elan A Cohen, Jean-Pierre Lindenmayer, J Corey Reuteman-Fowler> ;Neuropsychiatric Disease and Treatment. 2022 Jan 1
3 citations
Participant Engagement and Symptom Improvement: Aripiprazole Tablets with Sensor for the Treatment of Schizophrenia.
Jeffrey M Cochran, Hui Fang, Christophe Le Gallo, Timothy Peters-Strickland, Jean-Pierre Lindenmayer, J Corey Reuteman-Fowler> ;Patient Preference and Adherence. 2022 Jan 1
2 citations
Valbenazine Treatment of Tardive Dyskinesia and of Positive Symptoms.
Jean-Pierre Lindenmayer, Eugene Burke, Gabriel Tsuboyama, Yasmeen Chahal, Harpreet Kaur Grewal> ;Journal of Clinical Psychopharmacology. 2021 Oct 18
3 citations
Augmentation With Pimavanserin in Treatment Refractory Schizophrenia: Case Report.
Jean-Pierre Lindenmayer, Sukaina Rizvi> ;Journal of Clinical Psychopharmacology. 2021 May 1
Onset and Resolution of Key Adverse Events in Valbenazine-Treated Patients with Tardive Dyskinesia: Pooled Analyses from Two Long-Term Clinical Trials.
Stephen R. Marder, Jean-Pierre Lindenmayer, Chirag Shah, Tara Carmack, Angel S Angelov, Leslie Lundt> ;Cns Spectrums. 2021 Apr 1
53 citations
Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia: A Systematic Review and Meta-analysis.
Katsuhiko Hagi, Tadashi Nosaka, Dwight Dickinson, Jean-Pierre Lindenmayer, Jimmy Chee Keong Lee, Joseph H. Friedman, Laurent Boyer, Mei Han, Nur Amirah Abdul-Rashid, C...> ;JAMA Psychiatry. 2021 May 1
1 citations
Noninvasive direct current stimulation for schizophrenia: a review.
Jean-Pierre Lindenmayer, Brianna Fitapelli> ;Current Opinion in Psychiatry. 2021 Jan 29
17 citations
The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future Research.
Steven G. Potkin, John M. Kane, Christoph U. Correll, Jean-Pierre Lindenmayer, Ofer Agid, Stephen R. Marder, Mark Olfson, Oliver D. Howes> ;Focus. 2020 Nov 6
7 citations
The psychometric properties of the Self-Evaluation of Negative Symptoms Scale (SNS) in treatment-resistant schizophrenia (TRS).
Abraham Goldring, Sophia Borne, Amanda Hefner, Amod Thanju, Anzalee Khan, Jean-Pierre Lindenmayer> ;Schizophrenia Research. 2020 Oct 15
4 citations
Assessing instrumental activities of daily living (iADL) with a game-based assessment for individuals with schizophrenia.
Jean-Pierre Lindenmayer, Abraham Goldring, Sophia Borne, Anzalee Khan, Richard S.E. Keefe, Beverly J. Insel, Amod Thanju, Isidora Ljuri, Bronwen E Foreman> ;Schizophrenia Research. 2020 Sep 1
30 citations
Persistent Barriers to the Use of Long-Acting Injectable Antipsychotics for the Treatment of Schizophrenia.
Jean-Pierre Lindenmayer, Ira D. Glick, Hiteshkumar Talreja, Michael Underriner> ;Journal of Clinical Psychopharmacology. 2020 Jul 1
1 citations
A long-term, open-label study of valbenazine for tardive dyskinesia.
Jean-Pierre Lindenmayer, Cherian Verghese, Stephen R. Marder, Joshua Burke, Roland Jimenez, Scott Siegert, Grace S. Liang, Christopher F. O'Brien> ;CNS Spectrums. 2021 Aug 1
15 citations
A Modified Delphi Consensus Study of the Screening, Diagnosis, and Treatment of Tardive Dyskinesia
Stanley N. Caroff, Leslie Citrome, Jonathan M. Meyer, Martha Sajatovic, Joseph F. Goldberg, Rakesh Jain, Leslie Lundt, Jean-Pierre Lindenmayer, Joseph P. McEvoy, Roger...> ;The Journal of Clinical Psychiatry. 2020 Jan 28
150 citations
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research.
Steven G. Potkin, John M. Kane, Christoph U. Correll, Jean-Pierre Lindenmayer, Ofer Agid, Stephen R. Marder, Mark Olfson, Oliver D. Howes> ;NPJ Schizophrenia. 2020 Jan 7
100 citations
Cognitive remediation for schizophrenia: An expert working group white paper on core techniques
Christopher R. Bowie, Morris D. Bell, Joanna M. Fiszdon, Jason K. Johannesen, Jean Pierre Lindenmayer, Susan R. McGurk, Alice Medalia, Rafael Penadés, Alice M. Saperst...> ;Schizophrenia Research. 2020 Jan 1
1 citations
Pisa Syndrome and Aripiprazole.
Connor Smith, Naomi Gwynn, Jean-Pierre Lindenmayer> ;Journal of Clinical Psychopharmacology. 2020 Jan 1
9 citations
Differential improvement of negative-symptom subfactors after cognitive remediation in low-functioning individuals with schizophrenia.
Serge Sevy, Jean-Pierre Lindenmayer, Anzalee Khan, Isidora Ljuri, Mila Kirstie C. Kulsa, Owen Jones> ;Schizophrenia Research. Cognition. 2020 Mar 1
18 citations
A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia
Stephen R. Marder, Carlos Singer, Jean-Pierre Lindenmayer, Caroline M. Tanner, Cynthia L. Comella, Cherian Verghese, Roland Jimenez, Grace S. Liang, Joshua Burke, Chri...> ;Journal of Clinical Psychopharmacology. 2019 Nov 1
2 citations
Validation of the MUSIC Model of Motivation Inventory for use with cognitive training for schizophrenia spectrum disorders: A multinational study.
Marie C. Hansen, Brett D. Jones, Shaun M. Eack, Louise Birkedal Glenthøj, Satoru Ikezawa, Tatsuro Iwane, Sean A. Kidd, Martin Lepage, Jean Pierre Lindenmayer, Isidora ...> ;Schizophrenia Research. 2019 Apr 1
130 citations
Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia
John M. Kane, Ofer Agid, Marjorie L. Baldwin, Oliver D. Howes, Jean-Pierre Lindenmayer, Stephen R. Marder, Mark Olfson, Steven G. Potkin, Christoph U. Correll> ;The Journal of Clinical Psychiatry. 2019 Mar 5
38 Global Improvement and Patient Satisfaction: Results from a Long-term, Open-label, Rollover Study of Valbenazine in Tardive Dyskinesia.
Verghese, C.,Lindenmayer, J. P.,Marder, S. R.,Burke, J.,Jimenez, R.,Yonan, C.,Farahmand, K.,Siegert, S.> ;CNS Spectr. 2019 Mar 13
77 Long-term Valbenazine Treatment in Patients with Schizophrenia/Schizoaffective Disorder or Mood Disorder and Tardive Dyskinesia.
Lindenmayer, J. P.,Marder, S. R.,Singer, C.,Comella, C.,Farahmand, K.,Burke, J.,Jimenez, R.,Siegert, S.> ;CNS Spectr. 2019 Mar 13
Join now to see all

Other Languages

French, German

Hospital Affiliations

Manhattan Psychiatric Center-Ward's IslandNew York, New York

Jean-PierreLindenmayerMD

Dr. Lindenmayer is on Doximity

Education & Training

Certifications & Licensure

Awards, Honors, & Recognition

Clinical Trials

Publications & Presentations

Other Languages

Hospital Affiliations

Viewing the full profile is available to verified healthcare professionals only.